Stocktoria
CHAMPIONS ONCOLOGY, INC. CSBR
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 1988-11-30
CHAMPIONS ONCOLOGY, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | 8.0% | -14.7% | -9.8% | 1.2% | 0.9% |
| Net margin | 8.3% | -14.5% | -9.9% | 1.1% | 0.9% |
| FCF margin | 12.3% | -13.9% | 2.0% | 8.4% | -12.1% |
| Return on assets | 14.5% | -27.8% | -15.5% | 1.5% | 1.3% |
| Return on equity | 124.6% | 382.3% | -115.1% | 6.0% | 4.9% |
| Current ratio | 0.94 | 0.63 | 0.90 | 1.13 | 1.13 |
| Revenue growth | 13.5% | -6.9% | 9.7% | 19.7% | 27.8% |
Source: SEC EDGAR filings · CIK 0000771856 · as of 2025-04-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.